SUB-TYPE: CLASS 4 CAUTION IN USE
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
MHRA drug alert date: 21st March 2024
MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-fresenius-kabi-limited-sodium-chloride-intravenous-infusion-0-dot-9-percent-freeflex-el-24-a-slash-10
Pip code | Product description | Supplier | Batch Numbers |
Alliance do not stock | Sodium Chloride Intravenous Infusion 0.9% Freeflex. | Fresenius Kabi | 13SMR091 |
This is a caution in use only we are not accepting stock returns
Further information
For more information or medical information queries please email Medical.Information-UK@fresenius-kabi.com or telephone +44 (0)1928533575
For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758
SUB-TYPE: FIELD SAFETY NOTICE
Field safety notice-Carboflex dressings
We have received a recall from Convatec regarding two sizes of Carboflex dressings
Date of recall: 19/03/24
PIP CODE | DESCRIPTION | SUPPLIER | AFFECTED BATCH |
2527372 | CARBOFLEX N/ADH S7661 8X15CM | CONVATEC VIA NWOS | 3J02333 |
2527380 | CARBOFLEXN/ADH S7662 15X20CM | CONVATEC LTD (WOUNDCARE) | 3J00675 |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 3 RECALL
Besins Healthcare (UK) Ltd has informed the MHRA that a defective pump system was detected in two batches of Oestrogel Pump-Pack 750 micrograms/actuation Gel.
Pip code | Product description | Supplier | Batch Numbers |
2171775 | OESTROGEL CAN | BESINS HEALTHCARE (ALLFS) | 74800 74830 |
Further Information
For medical information enquiries please contact the Besins Healthcare UK Ltd Medical Information via email besins@eu.propharmagroup.com or by calling +44 (0)1748 828 789.
For stock control enquiries please contact Besins Healthcare UK Ltd Supply Chain via email supplychain-bhuk@besins-healthcare.com.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 2 RECALL
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
MHRA drug alert date:12/03/24
Pip code | Product description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | Sodiofolin 50 mg/ml, solution for injection/infusion 8ml | medac GmbH | E230320B |
Further Information
For all medical enquiries, please contact medical information at medac Pharma LLP by email to info@medacpharma.co.uk or by telephone 01786 458086
SUB-TYPE: FIELD SAFETY NOTICE
This is an update to the previous field safety notice first distributed 21/12/23
A customer response form is being circulated, if you had received any affected stock please complete and return to the address listed: QA@evolan.se
We have received a Recall from EVOLAN PHARMA on VISCOPASTE BANDAGE 4948 7.5CMX6M
Date of recall: 21st December 2023
MHRA FSN Link: https://www.gov.uk/drug-device-alerts/field-safety-notices-fsns-from-18-to-22-december-2023
Pip code | Product description | Supplier | Batch Numbers |
0332734 | VISCOPASTE BNDG 4948 7.5CMX6M | EVOLAN PHARMA (MEDICAL) | D300381 |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.
MHRA drug alert date: 26th February 2024
Pip code | Product | Supplier | Affected Batches |
8436313 | P.I CONCERTA XL TAB 18MG | Orifarm UK | 3EE35801 |
8436370 | P.I CONCERTA XL TAB 36MG | Orifarm UK | 3AE07102 3GE50002 |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information and stock control queries please email jacook@Orifarm.com, or telephone 01923 204333.
SUB-TYPE: CLASS 2 RECALL
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion, batch number SJFN5, due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA. This is because the Phase III study (STAND) of Adakveo in sickle cell disease patients with vaso-occlusive crises did not confirm its clinical benefit. As a consequence, the conditional marketing authorisation in the UK is being revoked.
MHRA drug alert date:21/02/24
Pip code | Product description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | Adakveo 10 mg/ml | Novartis Pharmaceuticals UK Limited | SJFN5 |
Further Information
For medical information enquiries please contact Novartis Pharmaceuticals UK Limited at: https://www.novartis.com/uk-en/contact/contact-us, by email: medinfo.uk@novartis.com or via telephone: +44 1276 698370.
For stock control enquiries please contact: commercial.team@novartis.com
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: CLASS 3 RECALL
Torrent Pharma (UK) Limited is recalling certain batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.
Pip code | Product Description | Affected Batches |
1111681 | RAMIPRIL TAB 1.25MG (TORRENT PHARMA) | MG21264 |
6290688
| RAMIPRIL TAB 1.25MG (TORRENT PHARMA) | MG21264 |
Further Information
For medical information enquiries please contact APCER Life Sciences, via telephone: 0800 0885366, or email: Medinfo.Torrent@apcerls.com
For stock control enquiries please contact the Torrent Pharma (UK) Limited Customer Service & Sales Executive via telephone: 01293 574188,or email: luke.davies@torrentpharma.co.uk or priti.pragji@torrentpharma.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: CLASS 4 CAUTION IN USE
Exeltis UK Limited has informed the MHRA regarding an inconsistency in the Patient Information Leaflet (PIL) packaged in cartons of the specified batches of Gepretix 100mg capsules.
MHRA drug alert date: 1st February 2024
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-exeltis-uk-limited-gepretix-100mg-capsules-el-24-a-slash-04#contents
Pip code | Product | Supplier | Affected Batches |
5401419 | GEPRETIX 100MG CAP | EXELTIS HEALTHCARE | LF32022A |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information enquiries please contact Uk.medinfo@exeltis.com or telephone 01494411775.
For stock control enquiries please contact uk.office@exeltis.com
SUB-TYPE: CLASS 4 CAUTION IN USE
Crescent Pharma Limited has informed the MHRA regarding an error with the European Article Number (EAN) barcode on the cartons of the above-mentioned batches of Pantoprazole 40 mg Gastro-Resistant Tablets distributed by Crescent Pharma Limited.
MHRA drug alert date: 30th January 2024
Pip code | Product | Supplier | Affected Batches |
1159664 | PANTOPRAZOLE EC TAB 40MG ALM | ALMUS PHARMACEUTICALS LTD | ET571E3001 |
1123850 | PANTOPRAZOLE TAB 40MG ACC | ACCORD SCHEME | ET571E3001 |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information enquiries please contact pharmacovigilance-eu@cadilapharma.com or telephone: +44 1217901596
For stock control enquiries please contact info@crescentpharma.com or telephone: 01256 772730